Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 1/20 | 0.42 |
| ▸ | GRM5 | P41594 | 2/20 | 0.36 |
| ▸ | MAT2A | P31153 | 5/20 | 0.36 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.34 |
| ▸ | SGPL1 | O95470 | 2/20 | 0.33 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.33 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.32 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.32 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20150383 | 0.95 | GRM5 (0.37) | KIF11GRM5MAT2APTGDR2S1PR1 | |
| SCHEMBL20114533 | 0.92 | KIF11 (0.42) | KIF11GRM5MAT2APTGDR2SGPL1 | |
| SCHEMBL20150377 | 0.91 | PTGER4 (0.36) | KIF11PTGER4 | |
| SCHEMBL20155963 | 0.90 | PTGER4 (0.34) | KIF11GRM5PTGER4GPBAR1PDPK1 | |
| SCHEMBL20156176 | 0.90 | PTGER4 (0.36) | GRM5PTGER4 | |
| SCHEMBL20996884 | 0.88 | KIF11 (0.39) | KIF11GRM5MAT2APDPK1 | |
| SCHEMBL21108306 | 0.88 | KIF11 (0.43) | KIF11GRM5MAT2APDE10A | |
| SCHEMBL20114551 | 0.86 | TDO2 (0.35) | PTGER4PDE10A | |
| SCHEMBL20156271 | 0.86 | GRM5 (0.37) | KIF11GRM5MAT2APTGDR2S1PR1 | |
| SCHEMBL21108008 | 0.86 | KIF11 (0.43) | KIF11GRM5MAT2APTGER4S1PR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10421746-B2 | Organic molecules, especially for use in organic optoelectronic devices | CYNORA GMBH (DE) | 2019-09-24 | — | — | US | disclosed |
| EP-3315581-B1 | ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2019-01-02 | — | — | EP | disclosed |
| US-20180134686-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2018-05-17 | — | — | US | disclosed |
| US-20180134686-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2018-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180134686-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, EPCAM, F12 | KIF11 2577/4885GRM5 4002/4885MAT2A 2283/4885 |
| US-10421746-B2 | Organic molecules, especially for use in organic optoelectronic devices | OR10J3, EPCAM, F12 | KIF11 2577/4885GRM5 4002/4885MAT2A 2283/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.